-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZcuLSXJZXLz9Y2LECTWqVJ
November 01, 2009 - METHODS
The USPSTF and Agency for Healthcare Research
and Quality (AHRQ) developed the key questions … Study Selection
We selected studies on the basis of inclusion and ex-
clusion criteria developed for … By using
predefined criteria developed by the USPSTF (21), 2
investigators rated the quality of each … Role of the Funding Source
The AHRQ funded this work, provided project
oversight, developed key questions
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary9/breast-cancer-screening-2009
November 15, 2009 - The USPSTF and Agency for Healthcare Research and Quality (AHRQ) developed … Study Selection
We selected studies on the basis of inclusion and exclusion criteria developed for … By using predefined criteria developed by the USPSTF, 21 2 investigators rated the quality of each study … Role of the Funding Source
The AHRQ funded this work, provided project oversight, developed key questions
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary9/alcohol-misuse-screening-and-behavioral-counseling-interventions-in-primary-care-2013
September 25, 2012 - Methods
We developed … Investigators developed key questions and created an analytic framework that incorporated the key questions … Study Selection
We developed inclusion and exclusion criteria with respect to populations, interventions … We assessed the quality (internal validity) of studies using predefined criteria based on those developed
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/syphilis-infection-in-pregnancy-screening-september-2018
August 31, 2017 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Research Plan
Syphilis Infection in Pregnant Women: Screening
August 31, 2017
Recommendations made by the USPSTF are independent of the U.S. government. The…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/MZB7xxWHfLHtcdT9uUHsrp
April 01, 2009 - Screening Tests
Instruments developed for primary care (Patient Health
Questionnaire for Adolescents
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
April 15, 2013 - Key questions were developed through the Effective Health Care Program and modified for the USPSTF. … Study Selection
We developed selection criteria for studies based on the patient populations, interventions … As a group, investigators used methods developed by the USPSTF to assess the overall quality of the body … From these data, the model was developed to allow the prediction of individualized absolute risk (probability … & Developed using secondary data sources with inadequate description of the population and duration
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-primary-care-screening-for-and-treatment-of/depression-in-adults-screening
January 26, 2016 - and older and pregnant or postpartum (within 1 year of birth at enrollment) and living in "very high-developed … meet criteria for fair or good quality (ie, it was poor quality) using study design–specific criteria developed … a Quality assessed using criteria developed by the US Preventive Services Task Force. 16
b Group … a Quality assessed using criteria developed by the US Preventive Services TaskForce. 16
b Group assignment … a Quality assessed using criteria developed by the US Preventive Services Task Force 16 for randomized
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-x-factors-consider-when-recommending-screening-intervals
July 01, 2017 - Procedure Manual Appendix X. Factors to Consider When Recommending Screening Intervals
Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence regarding the following factors should be considered when recommending a scree…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/RoC9VuSorM_LR7sTvLeFF2
July 01, 2008 - Patients in either group who developed
symptomatic urinary infections were also treated with the
study
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
November 01, 2014 - High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress
HIGH-PRIORITY
EVIDENCE GAPS
FOR CLINICAL PREVENTIVE SERVICES
Fourth Annual
REPORT TO CONGRESS
November 2014
SUBMITTED BY:
Dr. Michael LeFevre, Chair
Dr. Kirsten Bibbins-Domingo, Vice Chair
Dr. Albert Siu, Vice Chair
ON …
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
November 01, 2014 - High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress
HIGH-PRIORITY
EVIDENCE GAPS
FOR CLINICAL PREVENTIVE SERVICES
Fourth Annual
REPORT TO CONGRESS
November 2014
SUBMITTED BY:
Dr. Michael LeFevre, Chair
Dr. Kirsten Bibbins-Domingo, Vice Chair
Dr. Albert Siu, Vice Chair
ON …
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-type-2-in-adults-screening-2008
June 15, 2008 - Definitions of diabetes were originally developed by using results of 2-hour postload plasma glucose … The criterion for an abnormal fasting plasma glucose level was developed on the basis of 2-hour postload
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annual-report-to-congress-2017%20(2).pdf
January 01, 2017 - These organizations
and agencies provide input on the recommendations as they are being developed and
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
April 08, 2014 - based MFMU (Maternal-Fetal Medicine Units) trial instructed women to stop treatment if preeclampsia developed … Preterm birth is the cause of 70% of neonatal mortality and 75% of neonatal morbidity in developed countries
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cognitive-impairment-in-older-adults-screening
October 19, 2017 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Research Plan
Cognitive Impairment in Older Adults: Screening
October 19, 2017
Recommendations made by the USPSTF are independent of the U.S. government. They should no…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/chronic-obstructive-pulmonary-disease-screening-2016
April 05, 2016 - Scope of the Review
To conduct this review, an analytic framework was developed … Although the LFQ was specifically developed in the National Health and Nutrition Examination Survey population
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/_ZPNC3vqdS3R-ggXro6UAM
April 05, 2016 - Screening for Chronic Obstructive Pulmonary Disease: USPSTF Recommendation Statement
Copyright 2016 American Medical Association. All rights reserved.
Screening for Chronic Obstructive Pulmonary Disease
US Preventive Services Task Force
Recommendation Statement
US Preventive Services Task Force (USPSTF)
T he US Pre…
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/usptf-annual-report-congress-2018%20(1).pdf
January 01, 2018 - These
organizations and agencies provide input on the recommendations as they are being developed and
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/folic-acid-suppl-draft-rec-bulletin.pdf
March 20, 2023 - Task Forces Issues Draft Recommendation Statement on Folic Acid Supplementation to Prevent Neural Tube Defects
www.uspreventiveservicestaskforce.org 1
Task Force Issues Draft Recommendation Statement on
Folic Acid Supplementation to Prevent Neural Tube Defects
Taking folic acid before and during early…
-
www.uspreventiveservicestaskforce.org/USPSTF_Admin/Home/GetFile/1/996/syphilup/pdf
July 01, 2004 - with a group
given a single benzathine penicillin G injection.31
None of the patients in either group developed … New tests are being developed, particularly those related to on-site testing
or improved testing in newborns